Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Public Policy

Influencing national, EU, and global health policy and informing medical oncologists


Public Policy

Steered by the ESMO Public Policy Committee, ESMO works to represent the voice of medical oncology in global, regional and national policy-making, aiming to ensure that our members’ priorities are reflected in health policies across the world. For more information, please download our Public Policy Brochure.

Read more

ESMO Patient Advocates Working Group (PAWG)

The PAWG supports the work of the Public Policy Committee to deliver policy solutions that optimise patient care, improve cancer-specific information and education, and strengthen both patient autonomy and rights.

Read more

ESMO Cancer Medicines Committee

The ESMO Cancer Medicines Committee works to address the topic of access to medicines at the European and global policy levels to ensure that all patients have access to the medicines they need, when they need them. 

Read more

ESMO Election Manifesto

Public Policy News

ESMO Rare Cancers Working Group

The ESMO Rare Cancers Working Group is a 36 partner strong multi-stakeholder partnership, bringing together scientific societies, patient and research organisations, healthcare providers, and the industry. 

Read more


ESMO collaborates at the highest political levels with the World Health Organization (WHO) on issues related to cancer prevention and control.

Read more


ESMO has partnered with IARC - the WHO’s specialised cancer agency on cancer - to develop their World Cancer Report Updates learning platform to promote research into prevention to help reduce the global burden of cancer.

Read more


ESMO has ‘Special Consultative Status’ with the UN Economic and Social Council (UN ECOSOC) since 2020, enabling ESMO to drive UN resolutions and political declarations on cancer.

Read more

Air Pollution

Helping to prevent lung cancer cases in Europe by tightening EU laws on air pollution.



Lowering the incidence of cancer by helping to secure decreased occupational exposure limits to asbestos, a highly dangerous carcinogenic. 


EU Pharmaceuticals Legislation

Shaping pharmaceuticals legislation to improve the availability, accessibility and affordability of innovative medicines for cancer patients.


EU Research Funding

Securing cancer as a research priority in Horizon Europe and the 10th EU Framework Programme.


Health Emergencies

Ensuring that cancer patients’ interests are included in updated international preparedness strategies and planning for health emergencies.


Health Technology Assessment (HTA)

Informing HTA (Health Technology Assessment) processes and leveraging ESMO’s tools - including the ESMO-MCBS and ESCAT - to improve accessibility to innovative cancer treatments. 


Healthcare Workforce

Improving the health financing, recruitment, training, and retention of the oncology workforce.


Right to Be Forgotten

Securing equal treatment and non-discrimination of cancer survivors in EU financial services. 


Tobacco Policy

Fighting the tobacco epidemic to protect public health and reduce preventable cancer cases. 


Universal Health Coverage (UHC)

Supporting the delivery of universal health coverage to ensure the continued and timely access to affordable essential health services. 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.